Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes

S Mishra, CBB Gray, S Miyamoto, DM Bers… - Circulation …, 2011 - Am Heart Assoc
S Mishra, CBB Gray, S Miyamoto, DM Bers, JH Brown
Circulation research, 2011Am Heart Assoc
Rationale: Differential effects of δB and δC subtypes of Ca2+/calmodulin-dependent protein
kinase (CaMKII) on cardiomyocyte Ca2+ handling and survival have been suggested to
result from their respective nuclear versus cytosolic localizations. CaMKIIδ subtype
localization and its relationship to enzyme activation and target phosphorylation have not,
however, been systematically evaluated. Objective: To determine whether CaMKIIδ
subtypes are restricted to a particular subcellular location and assess the relationship of …
Rationale:
Differential effects of δB and δC subtypes of Ca2+/calmodulin-dependent protein kinase (CaMKII) on cardiomyocyte Ca2+ handling and survival have been suggested to result from their respective nuclear versus cytosolic localizations. CaMKIIδ subtype localization and its relationship to enzyme activation and target phosphorylation have not, however, been systematically evaluated.
Objective:
To determine whether CaMKIIδ subtypes are restricted to a particular subcellular location and assess the relationship of localization to enzyme activation and function.
Methods and Results:
CaMKIIδ is highly expressed in mouse heart and cardiomyocytes and concentrated in sarcoplasmic reticulum (SR)/membrane and nuclear fractions. CaMKIIδB and δC subtypes differ by a nuclear localization sequence, but both are present in nuclear and SR/membrane fractions. Nonselective subtype distribution is also seen in mice overexpressing CaMKIIδB or δC, even in a CaMKIIδ null background. Fluorescently tagged CaMKIIδB expressed in cardiomyocytes concentrates in nuclei whereas δC concentrates in cytosol, but neither localization is exclusive. Mouse hearts exposed to phenylephrine show selective CaMKIIδ activation in the nuclear (versus SR) compartment, whereas caffeine selectively activates CaMKIIδ in SR (versus nuclei), independent of subtype. Compartmentalized activation extends to functional differences in target phosphorylation at CaMKII sites: phenylephrine increases histone deacetylase 5 phosphorylation (Ser498) but not phospholamban (Thr17), whereas the converse holds for caffeine.
Conclusions:
These studies demonstrate that CaMKIIδB and δC are not exclusively restricted to the nucleus and cytosol and that spatial and functional specificity in CaMKIIδ activation is elicited by mobilization of different Ca2+ stores rather than by compartmentalized subtype localization.
Am Heart Assoc